Advertisement
Advertisement
ENVB
Enveric Biosciences, Inc. Common Stock
1.51
USDSponsored
-0.16
-9.58%
Aug 06, 13:39 UTC -4
Open
ENVB Earnings Reports
Positive Surprise Ratio
ENVB beat 11 of 16 last estimates.
69%
Next Report
Next Week
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Enveric Biosciences, Inc. Common Stock earnings per share and revenue
On May 13, 2026, ENVB reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Ligand Pharmaceuticals Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.90
Actual
$2.37
Surprise
+24.56%
Tarsus Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.21
Actual
-$0.43
Surprise
-101.03%
Iovance Biotherapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.11
Surprise
+14.53%
Intellia Therapeutics, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.81
Actual
-$0.80
Surprise
+1.86%
Immunocore Holdings plc - ADR
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
-$0.02
Surprise
-356.41%
MBX Biosciences, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.78
Surprise
-22.16%
Monte Rosa Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.43
Surprise
-9.58%
Novavax Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.41
Actual
-$0.32
Surprise
+22.65%
Prime Medicine, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.26
Actual
-$0.24
Surprise
+8.57%
SAB Biotherapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+5.15%
FAQ
What were Enveric Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Enveric Biosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Enveric Biosciences, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Enveric Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Enveric Biosciences, Inc. Common Stock's next earnings report?
Based on --
analysts, Enveric Biosciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement